Open AccessCOVID-19 AND BRONCHIAL ASTHMA
Author(s) -
Dimo Dimov,
T. Atanasov
Publication year - 2021
Publication title -
trakia journal of sciences
Language(s) - English
Resource type - Journals
eISSN - 1313-3551
pISSN - 1312-1723
DOI - 10.15547/tjs.2021.02.012
Subject(s) - asthma , covid-19 , medicine , respiratory tract , disease , coronavirus , respiratory disease , hypoxia (environmental) , intensive care medicine , respiratory system , lung , immunology , infectious disease (medical specialty) , pathology , outbreak , chemistry , organic chemistry , oxygen
Severe coronavirus disease-19 (COVID-19) presents with progressive dyspnea, resulting from acute lung inflammatory edema leading to hypoxia. Asthma has been cited as a potential risk factor for severe COVID-19 like other diseases that affect the respiratory tract. However, so far conflicting results have been published over the last few months and there is still no prove that there is a putative association between these two diseases. In the current mini-review we attempt to summarize the available information from the scientific literature concerning the relation of Bronchial asthma and the severity and clinical course of COVID-19 disease.